FDA Drug recall D-0572-2026
HyVee, Ultra Strength Antacid, Calcium Carbonate 1000 mg, 72 CHEWABLE TABLETS, DISTRIBUTED BY: HY-VEE INC., Inc., WEST DES MOINES, IA 50266…
- FDA Drug
- Class II
- ongoing
- Published 2026-06-10
On 2026-06-10 the FDA classified a Class II recall of HyVee, Ultra Strength Antacid, Calcium Carbonate 1000 mg, 72 CHEWABLE TABLETS, DISTRIBUTED BY: HY-VEE INC., Inc., WEST DES MOINES, IA 50266… by Guardian Drug, citing presence of foreign substance: small metallic particles in chewable tablets.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0572-2026 |
| Classification | Class II |
| Status | ongoing |
| Initiated | 2026-05-28 |
| Published | 2026-06-10 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Guardian Drug |
| Distribution | US |
Product
HyVee, Ultra Strength Antacid, Calcium Carbonate 1000 mg, 72 CHEWABLE TABLETS, DISTRIBUTED BY: HY-VEE INC., Inc., WEST DES MOINES, IA 50266, UPC: 0 75450 82514 5.
Reason
Presence of foreign substance: small metallic particles in chewable tablets.
Identifiers
| upc | 075450825145 |
|---|---|
| code_info | Lot #: 1716089, expires: JAN 2029. |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0572-2026%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.